64 filings
8-K
DNTH
Dianthus Therapeutics Inc
9 May 24
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results
4:08pm
8-K
DNTH
Dianthus Therapeutics Inc
21 Mar 24
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial Results
4:04pm
8-K
DNTH
Dianthus Therapeutics Inc
22 Jan 24
Dianthus Therapeutics Announces $230 Million Private Placement
7:34am
8-K
DNTH
Dianthus Therapeutics Inc
8 Jan 24
Results of Operations and Financial Condition
8:02am
8-K
DNTH
Dianthus Therapeutics Inc
21 Dec 23
Other Events
4:16pm
8-K
8fis 16i2x
9 Nov 23
Dianthus Therapeutics Highlights Recent Business Achievements and Third Quarter 2023 Financial Results
4:09pm
8-K
kqhpk sth38nq9is9a
25 Oct 23
Changes in Registrant's Certifying Accountant
4:15pm
8-K/A
8oy1kk46
20 Sep 23
Results of Operations and Financial Condition
9:50pm
8-K
wrx878 3cxjqbh0b2ob4
12 Sep 23
Magenta Therapeutics Announces Completion of Merger with Dianthus Therapeutics and Implementation of Reverse Stock Split
4:05pm
8-K
brn6ucc iq
8 Sep 23
Submission of Matters to a Vote of Security Holders
5:19pm
8-K
bll85j2 ew0s07kra
19 May 23
Departure of Directors or Certain Officers
4:21pm
8-K
vnrzfjv920uy4hdj
3 May 23
Magenta Therapeutics and Dianthus Therapeutics Announce Merger Agreement
7:44am
8-K
egskd0o
6 Apr 23
Entry into a Material Definitive Agreement
8:27am
8-K
cecvjmk 3k9oxjh1avr
31 Mar 23
Entry into a Material Definitive Agreement
4:37pm
8-K
78ossbriloq3daw l6n
7 Feb 23
Results of Operations and Financial Condition
4:12pm
8-K
f9pldpq2ewgkv
2 Feb 23
Magenta Therapeutics to Explore Strategic Alternatives
5:02pm
8-K
1utwqx
25 Jan 23
Regulation FD Disclosure
4:09pm
8-K
6m41gghizppysq 9g
20 Dec 22
Magenta Therapeutics Provides Update for MGTA-117 Phase 1/2 Dose Escalation Clinical Trial
9:05am
8-K
cmn upv3gb
13 Dec 22
Magenta Therapeutics Presents Positive MGTA-117 Clinical Data at the American Society of Hematology (ASH) Annual Meeting and Provides Program Updates
8:36am
8-K
37q6s 618
3 Nov 22
Magenta Therapeutics Reports Third Quarter Financial Results
9:05am